Open Access

Erratum to: Honokiol activates AMP-activated protein kinase in breast cancer cells via LKB1-dependent pathway and inhibits breast carcinogenesis

  • Arumugam Nagalingam1,
  • Jack L. Arbiser2,
  • Michael Y. Bonner2,
  • Neeraj K. Saxena3 and
  • Dipali Sharma1Email author
Breast Cancer Research201719:39

DOI: 10.1186/s13058-017-0829-2

Received: 6 March 2017

Accepted: 6 March 2017

Published: 28 March 2017

The original article was published in Breast Cancer Research 2012 14:R35

Erratum

After the publication of this work [1], an error was noticed in Fig. 1b. An incorrect image was inadvertently shown for the soft-agar colony for MDA-MB-231 cells treated with 5.0 uM Honokiol. The correct figure is shown below. This error did not affect the findings or conclusions of the article.
Fig. 1

Honokiol inhibits clonogenicity and anchorage-independent growth of breast cancer cells. a MCF7 and MDA-MB-231 cells were treated with various concentrations of honokiol (HNK) (as indicated) and subjected to clonogenicity assay. Untreated cells, denoted with the letter “U”. Colonies containing >50 normal-appearing cells were counted. *, P < 0.005, compared with untreated controls. b Breast cancer cells were subjected to soft-agar colony-formation assay in the presence of various concentrations of honokiol for three weeks. Untreated cells are denoted with the letter “U”. Results are expressed as average number of colonies counted (in six micro-fields). *, P < 0.001, compared with untreated controls

Notes

Declarations

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Oncology, Johns Hopkins University School of Medicine and the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
(2)
Department of Dermatology, Emory University School of Medicine, Winship Cancer Institute
(3)
Department of Medicine, University of Maryland School of Medicine

Reference

  1. Nagalingam A, et al. Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis. Breast Cancer Res. 2012;14(1):R35.View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

© The Author(s). 2017

Advertisement